Literature DB >> 21854437

Two years of follow-up validates the echocardiographic criteria for the diagnosis and screening of rheumatic heart disease in asymptomatic populations.

Maneesha Bhaya1, Rajesh Beniwal, Sadiak Panwar, Raja Babu Panwar.   

Abstract

OBJECTIVES: Out of 1,059 school children aged 6-15 years, screened 2 years ago, 54 children were diagnosed with rheumatic heart disease (RHD) and put on penicillin prophylaxis. Significant regurgitation of mitral valves was detected in 39 cases of echocardiography diagnosed RHD, and in 15 cases significant regurgitation was detected to coexist with valve deformities. Three children had isolated mitral valve thickening without regurgitation. They were not given penicillin prophylaxis. These cases were followed up for 2 years.
METHODS: After 2 years, 54 children diagnosed with RHD and three children with isolated mitral valve thickening, were evaluated again. Lot quality assurance sampling was employed to screen a selected group of school children declared normal during the earlier evaluation. Lot was to be rejected, if, one child with significant regurgitation of mitral valve was found among the first 10 screened children of each of the 10 lots.
FINDINGS: No lot was rejected and thus it was inferred that the prevalence of new onset RHD was negligible in the subset declared normal 2 years ago. Isolated significant mitral regurgitation disappeared more often when present (35.9%) in comparison to when it (26.7%) was originally found coexistent with valve deformities.
CONCLUSIONS: Highlight of the study is the greater reversibility of earlier lesions as compared to the later stages of RHD. Spontaneous regression of isolated mitral valve thickening in two-thirds of the cases even without antibiotic prophylaxis, undermines the value of morphological criteria for the diagnosis of RHD.
© 2011, Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21854437     DOI: 10.1111/j.1540-8175.2011.01487.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  18 in total

Review 1.  World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline.

Authors:  Bo Reményi; Nigel Wilson; Andrew Steer; Beatriz Ferreira; Joseph Kado; Krishna Kumar; John Lawrenson; Graeme Maguire; Eloi Marijon; Mariana Mirabel; Ana Olga Mocumbi; Cleonice Mota; John Paar; Anita Saxena; Janet Scheel; John Stirling; Satupaitea Viali; Vijayalakshmi I Balekundri; Gavin Wheaton; Liesl Zühlke; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-02-28       Impact factor: 32.419

2.  Rheumatic heart disease screening by "point-of-care" echocardiography: an acceptable alternative in resource limited settings?

Authors:  Anita Saxena
Journal:  Transl Pediatr       Date:  2015-07

3.  The utility of handheld echocardiography for early rheumatic heart disease diagnosis: a field study.

Authors:  Andrea Beaton; Jimmy C Lu; Twalib Aliku; Peter Dean; Lasya Gaur; Jacqueline Weinberg; Justin Godown; Peter Lwabi; Grace Mirembe; Emmy Okello; Allison Reese; Ashley Shrestha-Astudillo; Tyler Bradley-Hewitt; Janet Scheel; Catherine Webb; Robert McCarter; Greg Ensing; Craig Sable
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-01-05       Impact factor: 6.875

Review 4.  Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis.

Authors:  Liesl Zühlke; Bongani M Mayosi
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

Review 5.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

6.  Echo-based screening of rheumatic heart disease in children: a cost-effectiveness Markov model.

Authors:  Justin P Zachariah; Mihail Samnaliev
Journal:  J Med Econ       Date:  2015-02-09       Impact factor: 2.448

7.  Measuring and reporting disease progression in subclinical rheumatic heart disease.

Authors:  Ganesan Karthikeyan
Journal:  Heart Asia       Date:  2016-11-28

Review 8.  Screening for rheumatic heart disease: current approaches and controversies.

Authors:  Kathryn Roberts; Samantha Colquhoun; Andrew Steer; Bo Reményi; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-11-13       Impact factor: 32.419

9.  Bmi1 and BRG1 drive myocardial repair by regulating cardiac stem cell function in acute rheumatic heart disease.

Authors:  Pingxi Xiao; Kai Zhang; Zhiwen Tao; Niannian Liu; Bangshun Ge; Min Xu; Xinzheng Lu
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

10.  Screening-detected rheumatic heart disease can progress to severe disease.

Authors:  Daniel Engelman; Gavin R Wheaton; Reapi L Mataika; Joseph H Kado; Samantha M Colquhoun; Bo Remenyi; Andrew C Steer
Journal:  Heart Asia       Date:  2016-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.